Showing results (21-30 of 39) with videos related to
Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|August 19, 2015
Hepatitis C virus genotype 4 resistance and subtype demographic characterization of patients treated with ombitasvir plus paritaprevir/ritonavirGretja Schnell, Rakesh Tripathi, Jill Beyer, et al.Antimicrobial Agents and Chemotherapy|December 24, 2014
In vitro activity and resistance profile of dasabuvir, a nonnucleoside hepatitis C virus polymerase inhibitorWarren Kati, Gennadiy Koev, Michelle Irvin, et al.Epilepsy & Behavior : E&B|June 17, 2018
Assessing depression severity with a self-rated vs. rater-administered instrument in patients with epilepsyShirin Jamal-Omidi, Christine Collins, Erin Fulchiero, et al.Antimicrobial Agents and Chemotherapy|June 24, 2015
Resistance analysis of baseline and treatment-emergent variants in hepatitis C virus genotype 1 in the AVIATOR study with paritaprevir-ritonavir, ombitasvir, and dasabuvirPreethi Krishnan, Rakesh Tripathi, Gretja Schnell, et al.Plos One|October 5, 2018
Hepatitis C virus genetic diversity by geographic region within genotype 1-6 subtypes among patients treated with glecaprevir and pibrentasvirGretja Schnell, Preethi Krishnan, Rakesh Tripathi, et al.Nature Communications|June 16, 2015
A novel mechanism of generating extracellular vesicles during apoptosis via a beads-on-a-string membrane structureGeorgia K Atkin-Smith, Rochelle Tixeira, Stephanie Paone, et al.Antimicrobial Agents and Chemotherapy|August 1, 2018
Pooled Resistance Analysis in Patients with Hepatitis C Virus Genotype 1 to 6 Infection Treated with Glecaprevir-Pibrentasvir in Phase 2 and 3 Clinical TrialsPreethi Krishnan, Tami Pilot-Matias, Gretja Schnell, et al.Antimicrobial Agents and Chemotherapy|December 3, 2014
In vitro and in vivo antiviral activity and resistance profile of ombitasvir, an inhibitor of hepatitis C virus NS5APreethi Krishnan, Jill Beyer, Neeta Mistry, et al.Antimicrobial Agents and Chemotherapy|December 9, 2015
Analysis of Hepatitis C Virus Genotype 1b Resistance Variants in Japanese Patients Treated with Paritaprevir-Ritonavir and OmbitasvirPreethi Krishnan, Gretja Schnell, Rakesh Tripathi, et al.Journal of Extracellular Vesicles|December 11, 2019
Extracellular vesicles containing oncogenic mutant β-catenin activate Wnt signalling pathway in the recipient cellsHina Kalra, Lahiru Gangoda, Pamali Fonseka, et al.Pageof 4